USD 3.99
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -33.27 Thousand | -58.87 Thousand | -34.87 Thousand | -57.28 Thousand | -59.49 Thousand | -47.14 Thousand |
Net Income | -38.31 Thousand | -68.04 Thousand | -90.02 Thousand | -110.12 Thousand | -99.37 Thousand | -94.95 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | 69.75 Thousand | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 2000.00 | 9171.00 | 9250.00 | 9950.00 | 565.00 | 11.65 Thousand |
Other non-cash items | 3035.00 | -69.75 Thousand | 45.89 Thousand | 42.88 Thousand | 39.31 Thousand | 36.15 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 23 Thousand | 71.74 Thousand | 34.87 Thousand | 57.28 Thousand | 59.49 Thousand | 47.14 Thousand |
Debt repayment | -23 Thousand | -71.74 Thousand | -34.87 Thousand | -57.28 Thousand | -59.49 Thousand | -47.14 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 23 Thousand | 143.49 Thousand | 69.75 Thousand | 114.57 Thousand | 118.98 Thousand | 47.14 |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | 2000.00 | 7650.00 | 9250.00 | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 2000.00 | 1521.00 | 9250.00 | 9950.00 | 565.00 | 11.65 Thousand |
Cash at beginning of period | 12.87 Thousand | - | - | - | - | - |
Cash at end of period | 2601.00 | 12.87 Thousand | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -10.27 Thousand | 12.87 Thousand | - | - | - | - |
Free Cash Flow | -33.27 Thousand | -58.87 Thousand | -34.87 Thousand | -57.28 Thousand | -59.49 Thousand | -47.14 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -14.06 Thousand | -8762.00 | -38.31 Thousand | -13.63 Thousand | -6030.00 | -8585.00 |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -12.68 Thousand | 5683.00 | 2000.00 | 6935.00 | 2532.00 | -3171.00 |
Other non-cash items | 1197.00 | 907.00 | 3035.00 | 873.00 | -1343.00 | 1343.00 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 30.5 Thousand | - | 23 Thousand | 8000.00 | - | 15 Thousand |
Debt repayment | -30.5 Thousand | - | -23 Thousand | -8000.00 | - | -15 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 30.50 | - | 23 Thousand | 8.00 | - | 30 Thousand |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | -12.68 Thousand | 5683.00 | 2000.00 | 6935.00 | -280.00 | -1905.00 |
Inventory | - | - | - | - | - | - |
Other working capital | -12.68 Thousand | 5683.00 | 2000.00 | 6935.00 | 2812.00 | -1266.00 |
Cash at beginning of period | 429.00 | 2601.00 | 12.87 Thousand | 425.00 | 5266.00 | 679.00 |
Cash at end of period | 5380.00 | 429.00 | 2601.00 | 2601.00 | 425.00 | 5266.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 4951.00 | -2172.00 | -10.27 Thousand | 2176.00 | -4841.00 | 4587.00 |
Free Cash Flow | -25.54 Thousand | -2172.00 | -33.27 Thousand | -5824.00 | -4841.00 | -10.41 Thousand |
TRTN-PA
688011
AMRAPLIN
CL8
S&SPOWER
CSSI